MX2019012220A - Vacunas que contienen patogenos de cerdo para uso no mixto asociado. - Google Patents

Vacunas que contienen patogenos de cerdo para uso no mixto asociado.

Info

Publication number
MX2019012220A
MX2019012220A MX2019012220A MX2019012220A MX2019012220A MX 2019012220 A MX2019012220 A MX 2019012220A MX 2019012220 A MX2019012220 A MX 2019012220A MX 2019012220 A MX2019012220 A MX 2019012220A MX 2019012220 A MX2019012220 A MX 2019012220A
Authority
MX
Mexico
Prior art keywords
vaccine
infection
associated non
virus
vaccines containing
Prior art date
Application number
MX2019012220A
Other languages
English (en)
Inventor
Hendrik Witvliet Maarten
Van Den Born Erwin
Sno Melanie
Arnoldus Christiaan Jacobs Antonius
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2019012220A publication Critical patent/MX2019012220A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Abstract

La presente invención pertenece a una combinación de una primera vacuna que comprende inmunógeno no replicante de circovirus porcino tipo 2 (PCV2) e inmunógeno no replicante de Mycoplasma hyopneumoniae y una segunda vacuna que comprende virus de síndrome reproductivo y respiratorio porcino (PRRS) vivos atenuados, para usarse en tratar de manera profiláctica un animal contra una infección con circovirus porcino tipo 2, una infección con Mycoplasma hyopneumoniae y una infección con virus de PRRS, mediante administración no mixta asociada de la primera vacuna y la segunda vacuna al animal. La invención también pertenece a un kit de partes que comprende la primera y segunda vacuna y a un método para proteger un animal contra tales infecciones usando estas vacunas.
MX2019012220A 2017-04-13 2018-04-12 Vacunas que contienen patogenos de cerdo para uso no mixto asociado. MX2019012220A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17166590 2017-04-13
PCT/EP2018/059389 WO2018189290A1 (en) 2017-04-13 2018-04-12 Vaccines containing swine pathogens for associated non-mixed use

Publications (1)

Publication Number Publication Date
MX2019012220A true MX2019012220A (es) 2019-12-09

Family

ID=58547447

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019012220A MX2019012220A (es) 2017-04-13 2018-04-12 Vacunas que contienen patogenos de cerdo para uso no mixto asociado.

Country Status (9)

Country Link
US (1) US11311614B2 (es)
EP (2) EP4335455A2 (es)
JP (2) JP2020513027A (es)
KR (1) KR20190134650A (es)
CN (1) CN110446502B (es)
CA (1) CA3058281A1 (es)
MX (1) MX2019012220A (es)
RU (1) RU2756767C2 (es)
WO (1) WO2018189290A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4138896A1 (en) * 2020-04-20 2023-03-01 Intervet International B.V. A combination of vaccines to prophylactically treat a pig

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
WO2002026250A2 (en) * 2000-09-29 2002-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Vaccines for proliferative ileitis
CN101189027A (zh) 2005-01-13 2008-05-28 贝林格尔·英格海姆维特梅迪卡有限公司 改良的prrs疫苗
CN101277717A (zh) 2005-09-09 2008-10-01 英特威国际有限公司 Pcv-2疫苗
CN109125721A (zh) 2005-12-29 2019-01-04 贝林格尔.英格海姆维特梅迪卡有限公司 Pcv2免疫原性组合物用于减轻猪临床症状的用途
PT2094872T (pt) 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
US8728487B2 (en) 2011-01-20 2014-05-20 Hua Wu Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9457073B2 (en) 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
KR102360690B1 (ko) 2013-12-03 2022-02-08 인터벳 인터내셔널 비.브이. Ｐｒｒｓ 및 로소니아 인트라셀룰라리스에 대한 돼지 백신
CA2931136C (en) 2013-12-03 2023-03-21 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2
WO2018115249A1 (en) * 2016-12-22 2018-06-28 Intervet International B.V. Needleless injector

Also Published As

Publication number Publication date
CN110446502B (zh) 2024-01-26
JP2023025210A (ja) 2023-02-21
JP2020513027A (ja) 2020-04-30
RU2019136252A3 (es) 2021-05-13
EP4335455A2 (en) 2024-03-13
CA3058281A1 (en) 2018-10-18
RU2019136252A (ru) 2021-05-13
KR20190134650A (ko) 2019-12-04
CN110446502A (zh) 2019-11-12
US11311614B2 (en) 2022-04-26
RU2756767C2 (ru) 2021-10-05
WO2018189290A1 (en) 2018-10-18
EP3609533A1 (en) 2020-02-19
US20200046825A1 (en) 2020-02-13

Similar Documents

Publication Publication Date Title
MX2019007349A (es) Vacuna combinada para cerdos.
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
RU2018127403A (ru) Поливалентная вакцина против hyo и ее применение
MX2018006416A (es) Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina.
MX2016007225A (es) Vacuna contra lawsonia intracellularis y circovirus porcino 2.
RU2018137034A (ru) Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae
MX2019012220A (es) Vacunas que contienen patogenos de cerdo para uso no mixto asociado.
MX2020006662A (es) Vacuna combinada intradermica contra mycoplasma y circovirus porcino.
BR112022019207A2 (pt) Composições de vacina para coronavírus e métodos de uso das mesmas
MX2016007226A (es) Vacuna para cerdos contra el sindrome reproductivo y respiratorio porcino y lawsonia intracellularis.
PH12018501750A1 (en) Porcine reproductive and respiratory syndrome vaccine virus
MX2022013080A (es) Una combinacion de vacunas para el tratamiento profilactico de un cerdo.
MX2020006061A (es) Una vacuna para proteccion contra streptococcus suis.
MX2022003090A (es) Vacuna combinada para ser administrable intradermicamente.
MX369039B (es) Vacuna contra el circovirus porcino tipo 2.
MX2022010373A (es) Vacuna contra el virus de la peste porcina africana.
RU2018137033A (ru) Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs
PH12019550018A1 (en) Porcine reproductive and respiratory syndrome virus cdna clone and uses thereof
JP2019512518A5 (es)
BR112018069193A2 (pt) uma vacina de combinação contra infecção por vírus pcv2 e prrs compreendendo albumina
UA122732U (uk) Вакцина проти репродуктивно-респіраторного синдрому цирковірусної та парвовірусної інфекції свиней асоційована інактивована емульсована
CL2023002187A1 (es) Virus para vacuna contra el síndrome respiratorio y reproductivo porcino
TH1801003840A (th) วัคซีนเอ็ม ไฮโอ มัลติวาเลนท์ และการใช้ของมัน
RU2022116197A (ru) Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae